The role of pharmacogenomics in personalized medicine: A focus on drug metabolism DOI Open Access

Ali Nasser Alsuwaileh,

Ibrahim A. Ibrahim,

‏Hammad Abdullah Aljaloud

и другие.

International Journal of Health Sciences, Год журнала: 2024, Номер 8(S1), С. 1844 - 1859

Опубликована: Янв. 15, 2024

Background: The conventional model of drug treatment may involve set protocols use and not the currently variegated pharmacology patterns due to mutations in metabolism enzymes. But recent innovations pharmacogenomics have provided new insight on feeds processing drugs through genetic environment components that present a more divergent view treatment. Aim: purpose this study is understand specificity framework individualized medicine its potential enhance efficacy safety lifestyle differences. Methods: A literature search was performed compare effects variations as metabolism. research also focuses at how testing used developing custom therapies. Results: major impact rate along with their effectiveness toxicity. Of course, assessing health-promoting behaviours include diet physical activity, or lack thereof, well others, can strongly therapeutic success. Conclusion: Potential for manufactured Meal ability highlight vests are crucial finding personalized treatments.

Язык: Английский

THE ROLE OF PHARMACISTS IN PERSONALISED MEDICINE: A REVIEW OF INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE DOI Creative Commons

Obe Destiny Balogun,

Oluwatoyin Ayo-Farai,

Oluwatosin Ogundairo

и другие.

International Medical Science Research Journal, Год журнала: 2024, Номер 4(1), С. 19 - 36

Опубликована: Янв. 8, 2024

This paper explores the transformative role of pharmacists in integrating pharmacogenomics into clinical practice. Pharmacogenomics, study genetic influences on drug response, presents an unprecedented opportunity to personalise medication management. The pharmacist's has evolved from dispensing becoming crucial interpreting and applying genomic data for optimised therapeutic outcomes. We delve foundations pharmacogenomics, historical milestones, its applications responsibilities include data, collaborating with healthcare providers, counselling patients, Medication Therapy Management. Challenges, such as ethical considerations legal frameworks, are navigated ensure responsible Education emerges a cornerstone, recommendations enhance literacy through comprehensive educational programs. Ethical highlight importance informed consent, privacy safeguards, equitable access pharmacogenomic information. future pharmacy practice relies interdisciplinary collaboration, continuous education, adherence, positioning integral contributors personalised medicine landscape. Keywords: Personalised Medicine, Pharmacy Practice, Genomic Literacy, Interdisciplinary Collaboration.

Язык: Английский

Процитировано

34

Integrating pharmacogenomic testing into personalized medicine practices in the USA: Implications for medication quality control and therapeutic efficacy DOI Creative Commons

James Tabat Bature,

Michael Alurame Eruaga,

Esther Oleiye Itua

и другие.

GSC Biological and Pharmaceutical Sciences, Год журнала: 2024, Номер 26(3), С. 019 - 026

Опубликована: Март 9, 2024

This concept paper explores the integration of pharmacogenomic testing into personalized medicine practices in USA and its implications for medication quality control therapeutic efficacy. By leveraging genetic information to optimize selection dosing, this aims improve patient outcomes minimize adverse drug reactions, thereby enhancing safety efficacy clinical practice. Integrating has potential revolutionize healthcare by improving USA. The begins discussing current landscape role optimizing dosing. It then examines benefits integrating practice, including improved safety, efficacy, cost-effectiveness. Key considerations implementing are discussed, regulatory considerations, reimbursement challenges, ethical considerations. also highlights importance provider education engagement successful implementation testing. Through a comprehensive analysis, provide insights testing, providers can personalize leading patients.

Язык: Английский

Процитировано

15

A call to action for ambulatory care pharmacists for the treatment of depression and anxiety in primary care: An opinion paper of the ambulatory care and central nervous system practice research networks of the American College of Clinical Pharmacy DOI Open Access
Richard J. Silvia, Insaf Mohammad, Clayton English

и другие.

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Год журнала: 2025, Номер unknown

Опубликована: Фев. 17, 2025

Abstract The need for mental health care has increased in recent years, especially due to the coronavirus disease 2019 pandemic. Simultaneously, supply of clinicians declined alongside decreases primary clinicians. As management depression and anxiety increasingly moved care, ambulatory pharmacists must be equipped with knowledge skills needed patients these illnesses. objective this collaborative Opinion Paper Ambulatory Care Central Nervous System Practice Research Networks is provide practical guidance on role educational needs within settings serve as a call action. authors performed narrative review PubMed database from January 1, 1990 November 10, 2024 using search terms pertaining care. reference lists articles were then reviewed additional references. can help meet Their evidence‐based medicine, drug interactions, adverse effects, other areas pharmaceutical coupled their training interprofessional team‐based make them an ideal addition team anxiety. A variety programs are available augment skills. Similarly, at all levels, student resident, should incorporate experiences prepare future address patients. leverage they possess fill gap living settings.

Язык: Английский

Процитировано

0

Understanding Adverse Drug Effects and The Clinical Pharmacist's Role in Their Management DOI Creative Commons

Farid Ahmad Tanin

Journal of Natural Science Review, Год журнала: 2024, Номер 2(4), С. 1 - 35

Опубликована: Дек. 30, 2024

Pharmacological interventions are the cornerstone of modern medical treatment, designed to address specific diseases, alleviate symptoms, and improve patients' quality life. However, misconceptions persist regarding drug effects, such as belief that all pharmacological effects beneficial side adverse. Clinical Pharmacists (CPs) play a crucial role in managing drug-related problems, but their contributions remain underrecognized Afghanistan. This study aims these emphasize CPs adverse (ADEs). A comprehensive literature review was conducted explore categorization ADE management. The findings reveal not always intended vital identifying risk factors polypharmacy characteristics, establishing therapeutic goals, mitigating ADEs. In conclusion, ineffectiveness lack efficacy should be categorized ADEs, contribute outcomes deemed Integrating more effectively into healthcare systems is essential optimize medication management, ensure safer treatments, enhance patient outcomes.

Язык: Английский

Процитировано

1

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments DOI Creative Commons
Marta Hernández, Natàlia Cullell, Marc Cendrós

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(2), С. 244 - 244

Опубликована: Фев. 7, 2024

Decades of pharmacogenetic research have revealed genetic biomarkers clinical response to antipsychotics. Genetic variants in antipsychotic targets, dopamine and serotonin receptors particular, metabolic enzymes been associated with the efficacy toxicity treatments. However, prediction based on these is far from accurate. Despite validity findings, utility remains unclear. Nevertheless, information CYP responsible for biotransformation most commercially available antipsychotics has proven be effective personalisation dosing, resulting a reduction induced side effects an increase efficacy. rarely used psychiatric settings as prescription aid. Lack studies cost-effectiveness, absence guidelines several commonly antipsychotics, cost testing delay results delivery hamper implementation interventions settings. This narrative review will comment existing information, their current future implementations.

Язык: Английский

Процитировано

0

The role of pharmacogenomics in personalized medicine: A focus on drug metabolism DOI Open Access

Ali Nasser Alsuwaileh,

Ibrahim A. Ibrahim,

‏Hammad Abdullah Aljaloud

и другие.

International Journal of Health Sciences, Год журнала: 2024, Номер 8(S1), С. 1844 - 1859

Опубликована: Янв. 15, 2024

Background: The conventional model of drug treatment may involve set protocols use and not the currently variegated pharmacology patterns due to mutations in metabolism enzymes. But recent innovations pharmacogenomics have provided new insight on feeds processing drugs through genetic environment components that present a more divergent view treatment. Aim: purpose this study is understand specificity framework individualized medicine its potential enhance efficacy safety lifestyle differences. Methods: A literature search was performed compare effects variations as metabolism. research also focuses at how testing used developing custom therapies. Results: major impact rate along with their effectiveness toxicity. Of course, assessing health-promoting behaviours include diet physical activity, or lack thereof, well others, can strongly therapeutic success. Conclusion: Potential for manufactured Meal ability highlight vests are crucial finding personalized treatments.

Язык: Английский

Процитировано

0